NCT00507858 Pemetrexed (Alimta) in Patients With Head and Neck Squamous Cell Cancer Status COMPLETED Phase PHASE1
NCT00507442 Phase 1/2 Study of VELCADE® in Combination With Other Drugs to Treat Previously Untreated Multiple Myeloma Patients Status COMPLETED Phase PHASE1/PHASE2
NCT00507416 Velcade,Thalidomide, and Dexamethasone Versus Velcade and Dexamethasone Versus Velcade, Melphalan, and Prednisone Status COMPLETED Phase PHASE3
NCT00501826 Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Status RECRUITING Phase PHASE2
NCT00492999 Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT00492284 Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL) Status COMPLETED Phase PHASE2
NCT00491127 Cisplatin With Gemcitabine With Dexamethasone in Patients With Aggressive Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE2
NCT00489307 Dexamethasone for Symptom Burden in Advanced Cancer Patients Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT00482261 A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression Status COMPLETED Phase PHASE2
NCT00479089 Iressa and Taxotere Study in Patients With Metastatic Urothelial Cancer Status TERMINATED Phase PHASE2
NCT00478777 A Multicenter, Single-Arm, Open-Label Expanded Access Program for Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma Status COMPLETED Phase PHASE3
NCT00478218 Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma Status COMPLETED Phase PHASE2
NCT00477971 Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed By Autologous Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis Status COMPLETED Phase PHASE3
NCT00477412 Bortezomib, Rituximab and Combination Chemotherapy in Treating Participants With Mantle Cell Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT00476593 Retinal OCT and (mfERG) Related to Age, Sex, and the Use of Anti-inflammatory Medications Status COMPLETED Phase NA
NCT00475085 Prevention of Delayed Nausea A Phase III Double-Blind Placebo-Controlled Clinical Trial Status COMPLETED Phase PHASE3
NCT00474188 A Study to Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Status TERMINATED Phase PHASE2
NCT00473512 A Safety and Efficacy Study of Abiraterone Acetate in Participants With Prostate Cancer Who Have Failed Hormone Therapy Status COMPLETED Phase PHASE1/PHASE2